Skip to content
Screener

Mannkind MNKD V Go — Intangible Amortization

Similar metrics at other companies

Netscout Systems logo
NTCTProduct — Intangible Amortization
$451K-28.4%
Netscout Systems logo
NTCTService — Intangible Amortization
$270K
Insmed logo
INSMAstraZeneca milestones — Intangible Amortization
$818K
Insmed logo
INSMPARI milestones — Intangible Amortization
$50K
lululemon athletica logo
LULUAmericas — Intangible Amortization
$0
AeroVironment logo
AVAVUxs — Intangible Amortization
$4.26M

Other financials

Income statement

See full
Revenue$109.4M+42.9%
Gross profit$95.0M+32.0%
Operating income-$350.0K-107%
Net income-$19.0M-2,949%
EPS (diluted)-$0.06

Balance sheet

See full
Cash & equivalents$52.9M-7.2%
Total debt$11.8M-7.5%
Total equity-$67.2M-22.1%
Total assets$732.3M+77.9%

Cash flow

See full
Operating cash flow-$18.4M-305%
CapEx$5.1M+355%
Free cash flow-$23.5M-399%

Valuation

See full
Market cap$1.32B+25.9%
Enterprise value$1.28B+27.4%
P/S3.4×-0.1×

Profitability

See full
Gross margin89.8%-4.8pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity44.2%
Debt / equity-0.2×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The source filing: Mannkind’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:07 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335054

Amortization expense related to the Developed technology – on-body infusor ("on-body infusor") was $4.3 million and $8.6 million for the three and six months ended June 30, 2026, respectively. The on-body infusor was acquired from scPharma in October 2025. See Note 2 – Business Combinations. The estimated annual amortization expense for the on-body infusor will be approximately $17.3 million per year for the years ending December 31, 2026 through 2036. Amortization expense related to the Developed technology – V-Go was de minimis and $0.1 million for the three and six months ended June 30, 2026 and de minimis and $0.1 million for the three and six months ended June 30, 2025. The estimated annual amortization expense for the Developed technology – V-Go will be approximately $0.2 million per year for the years ending December 31, 2026 through 2029.

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Mannkind's v go — intangible amortization?
Mannkind (MNKD) reported v go — intangible amortization of $100K in Q2 2026.
How has Mannkind's v go — intangible amortization changed year-over-year?
Mannkind's v go — intangible amortization decreased by 0.0% year-over-year, from $100K to $100K.
What does v go — intangible amortization mean?
The non-cash expense recognized during the reporting period for the systematic allocation of the cost of V-Go related intangible assets over their useful lives. This reflects the consumption of the economic benefits derived from the acquired product rights during the current period.

Ask your AI about Mannkind's v go — intangible amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude